Population Assessment of Tobacco and Health (Path) Study for the National Institute... Tender

Procurement Summary

Country : USA

Summary : Population Assessment of Tobacco and Health (Path) Study for the National Institute on Drug Abuse

Deadline : 02 Jun 2023

Other Information

Notice Type : Tender

TOT Ref.No.: 83195901

Document Ref. No. : 75N95023R00001

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

This is a PRE-SOLICITATION NOTICE AND SYNOPSIS. The National Institute on Drug Abuse (NIDA), in partnership with the Center for Tobacco Products (CTP) of the Food and Drug Administration (FDA) (collectively, the Government), plans to solicit proposals under full and open competition procedures from qualified organizations having the knowledge, expertise, experience and capability to continue collection of behavioral data and biospecimens among new participants, aged-up participants and continuing participants in a national longitudinal study.

BACKGROUND:

The Family Smoking Prevention and Tobacco Control Act (FSPTCA), signed by President Barack Obama on June 22, 2009, created the FDA Center for Tobacco Products (CTP) and granted it the authority to regulate the manufacturing, marketing, and distribution of tobacco products including cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco in order to protect public health. In 2016, FDA finalized a rule, commonly referred to as “deeming”, that extends FDA's regulatory authority to all tobacco products including electronic cigarettes or electronic nicotine delivery systems (ENDS), cigars, pipe tobacco, hookah tobacco, and other tobacco products such as nicotine gels. The Population Assessment of Tobacco and Health (PATH) Study is a national cohort study designed to generate longitudinal epidemiologic data on tobacco use behaviors including patterns of use, attitudes, beliefs, exposures, and related health outcomes. This study began in 2011 and is a collaboration between the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) and the U.S. Food and Drug Administration (FDA) Center for Tobacco Products. Wave 1 of the PATH Study began in 2013 and included the collection of questionnaire and biospecimen data with annual data collections through Wave 4, which began in 2016. The study transitioned to biennial data collection starting with Wave 5 in 2018.

T...
Active Contract Opportunity
Notice ID : 75N95023R00001
Related Notice : 75N95023R00001_SBSS
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office : NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: May 19, 2023 03:57 pm EDT
Original Response Date: Jun 02, 2023 11:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date:
Initiative: None

Classification
Original Set Aside:
Product Service Code: AN11 - Health R&D Services; Health care services; Basic Research
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance:

Documents

 Tender Notice